Axial3D, a leader in creating AI-powered 3D medical imaging algorithms, automated planning and patient specific 3D solutions, is thrilled to announce the completion of a new investment round totalling USD 18.2 million. This latest funding includes continued support from Axial3D’s first round investors
Techstart, Innovation Ulster Limited and US and NI business Angels as well as additional follow-on investment from Clarendon. It also welcomes three new strategic investors: 57 Stars, Whiterock, and Innovate UK. In particular, with its USD 10 million investment, 57 Stars will become the company’s largest shareholder.
"We are delighted to have completed this investment round, which will enable us to accelerate our mission of making patient-specific surgery routine globally," shared Roger Johnston, CEO of Axial3D.
Related: Axial3D to create 20 NI jobs with £3m investment and 300% revenue growth
Reflecting on the transformative potential of the new investment, he added, "Our market-fundamental patented technology platform empowers medical device companies, medical imaging companies, and hospitals to standardize the use of incredibly precise, patient specific 3D data that transforms their offerings for patients. Our AI technology has the power to impact millions of patients globally across patient specific applications in robotics, planning and patient specific device workflows."
The new investors see Axial3D as uniquely positioned to lead the steep change to scalable, patient-specific solutions. “Axial3D’s pioneering technology that creates patient specific 3D imaging has already shown incredible potential in the Medtech space,” said Bernie McGuire, Managing Director and IC Member of 57 Stars. “We are excited to support their ongoing technology application expansion and look forward to seeing the impact their innovations will make in advancing personalized healthcare.”
He further added, “this is the latest deal out of our long-standing Northern Ireland investment program, which has now committed over USD 50 million, and a prime example of our investment thesis of finding compelling opportunities at the intersection of healthcare and technology.”
Neil McCabe, Director of Whiterock, highlighted Axial3D’s potential to reshape healthcare with its market leading technology. “Axial3D’s technology addresses a critical need in healthcare—enabling scalability in personalized care. We’re proud to join this journey, supporting a company that is paving the way for more accessible and precise surgical solutions worldwide.”
